WebPlease see full Prescribing Information for BRAFTOVI and full Prescribing Information for MEKTOVI for additional information. INDICATIONS AND USAGE BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) are kinase inhibitors indicated for use in combination for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or … WebSide effects Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking MEKTOVI. Like other medicines, MEKTOVI can cause side effects but not everybody gets them. Some may be serious and need medical attention. Do not be alarmed by the following lists of side effects. You may not experience any of them.
MEKTOVI® tablets Pfizer
WebLong-term side effects of anti-cancer medications are specific to each medication. Not all anti-cancer or chemotherapy medications have long-term side effects, but several have been associated with memory difficulties (sometimes called "chemo brain"), heart problems, diabetes, numbness or tingling in hands and feet, fertility problems, or fatigue. WebNov 13, 2024 · For people with colorectal cancer with BRAF mutations, a treatment regimen that consists of three targeted cancer drugs—encorafenib (Braftovi), cetuximab (Erbitux), and binimetinib (Mektovi)—can improve how long they live without increasing their risk of serious side effects, results from the BEACON CRC trial show. solid state compact flash card
Mektovi Side Effects: Common, Severe, Long Term - Drugs.com
WebDec 12, 2024 · Feeling dizzy, tired, or weak. Stomach pain. Constipation, diarrhea, throwing up, and upset stomach are common with this drug. If these happen, talk with your doctor about ways to lower these side effects. Call your doctor right away if any of these effects bother you, do not go away, or get very bad. WebJun 23, 2024 · What are the side effects of Mektovi (Oral)? Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, … WebJun 1, 2016 · Vemurafenib also induced acute paronychia and brittle nails. All nail side effects were graded as G1. Hair and nail side effects during targeted therapy for melanoma are not rare. The early recognition and cure of such side effects by dermatologists is of benefit to ensure the need for dose reduction or drug discontinuation. solid state board connectors grease